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Background: Hypertension is a global public health challenge. National prevalence estimates can conceal
important differences in prevalence in subnational areas. This paper aims to develop a consistent set of national
and subnational estimates of the prevalence of hypertension in a country with limited data for subnational areas.
Methods: A nationally representative cross-sectional Survey of Lifestyle, Attitudes and Nutrition (SLÁN) 2007 was
used to identify risk factors and develop a national and a subnational model of the risk of self-reported,
doctor-diagnosed hypertension among adults aged 18+ years in the Republic of Ireland. The subnational
model’s group-specific risk estimates were applied to group-specific population count estimates for subnational
areas to estimate the number of adults with doctor-diagnosed hypertension in subnational areas in 2007. A
sub-sample of older adults aged 45+ years who also had their blood pressure objectively measured using a
sphygmomanometer was used to estimate the national prevalence of diagnosed and undiagnosed hypertension
among adults aged 45+ years.
Results: The prevalence of self-reported, doctor-diagnosed hypertension among adults aged 18+ years was
12.6% (95% CI = 11.7% - 13.4%). After adjustment for other explanatory variables the risk of self-reported,
doctor-diagnosed hypertension was significantly related to age (p < 0.001), body mass index (p < 0.001), smoking
(p = 0.001) and fruit and vegetable consumption (p = 0.003). Among adults aged 45+ years the prevalence of
undiagnosed hypertension (38.7% (95% CI 34.6% - 42.8%)) was higher than self-reported, doctor-diagnosed
hypertension (23.4% (95% CI = 22.0% - 24.7%)). Among adults aged 45+ years, the prevalence of undiagnosed
hypertension was higher among men (46.8%, 95% CI 41.2% - 52.4%) than women (31.2%, 95% CI 25.7% - 36.6%).
There was no significant variation in the prevalence of self-reported, doctor-diagnosed hypertension across
subnational areas.
Conclusions: Services need to manage diagnosed hypertension cases and to detect and manage undiagnosed
cases. Further population level improvements in lifestyle risk factors for hypertension are key in developing a
more integrated approach to prevent cardiovascular disease. Better subnational data on hypertension outcomes
and risk factors are needed to better describe the distribution of hypertension risk and hypertension prevalence
in subnational areas.
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Hypertension is a global public health challenge [1,2] re-
sponsible for significantly reduced quality of life and is a
risk factor strongly associated with cardiovascular disease
and premature mortality [3-5]. The prevalence of hyper-
tension is expected to increase as the population increases
and ages [6].
Population prevalence of hypertension is the proportion
of people living with hypertension in a population at or
during a particular time period. National prevalence can
conceal important differences in prevalence in subnational
areas [7]. Subnational estimates of the population preva-
lence of hypertension are essential for the development of
healthy and equitable communities. Subnational estimates
describe the pattern of disease in the local population and
support the planning and delivery of prevention and man-
agement services that meet local needs.
Estimates of the prevalence of hypertension in the Re-
public of Ireland range from 10% [8] to 62% [9] depending
on what outcomes, age groups and methods were used.
There is no consistent approach based on the national
health survey that provides national and subnational
prevalence estimates.
The Institute of Public Health in Ireland (IPH) has
produced national and subnational prevalence esti-
mates and forecasts for a number of chronic health
conditions. We first published diabetes prevalence esti-
mates and forecasts for the Republic of Ireland and
Northern Ireland [10,11] based on a prevalence model
developed in England by the Association of Public
Health Observatories (APHO) [12]. This model used
diabetes risks from an English population-based epi-
demiological study applied to population data from the is-
land of Ireland. We then adapted other APHO disease
prevalence models [12] based on the Health Survey for
England to estimate and forecast the prevalence of hyper-
tension, stroke, coronary heart disease and chronic airflow
obstruction on the island of Ireland [13,14]. Due to con-
cerns about using English data to estimate disease risks
for the island of Ireland, we further adapted the method-
ology for use with Republic of Ireland and Northern
Ireland data. Prevalence estimates and forecasts based on
this method and Irish data sources have been published
elsewhere [15,16].
This paper describes the method in detail and uses it
to produce a consistent set of national and subnational
estimates of the prevalence of hypertension for the Re-
public of Ireland. There are a number of significant limi-
tations in the subnational risk factor data available in the
Republic of Ireland. These limitations resulted in a num-
ber of compromises in our efforts to develop a system-
atic and rigorous methodology. This paper describes
these data limitations and how risk factor data could be
improved to produce better prevalence estimates.Methods
National model of hypertension risk
Data sources
The Survey of Lifestyle, Attitudes and Nutrition (SLÁN)
2007 [9], a cross-sectional survey of health and lifestyle,
was used to describe the risk of hypertension in the
Republic of Ireland. A nationally representative sample
of private households was selected from the country’s
GeoDirectory [17], the Irish address database. One adult
within a household was randomly selected to participate
in the survey. The survey comprised face-to-face de-
tailed health and lifestyle interviews with 10,364 respon-
dents aged 18+ years administered by trained social
interviewers as well as two physical measurement sub-
samples: anthropometric measures in a sub-sample of
967 respondents aged 18-44 years and a more detailed
physical examination of a sub-sample of 1,207 respon-
dents aged 45+ years. The response rate for the main
survey of adults aged 18+ years was 62% (n = 10,364).
The response rate within these respondents to the main
survey was 58% (n = 967) for the younger sub-sample
(aged 18-44 years) and 60% (n = 1,207) for the older
sub-sample (aged 45+ years). The full sample distribu-
tion and the sub-sample distributions were weighted to
population totals (for age, gender, marital status, eco-
nomic status, education, occupational category, ethni-
city, household size, and geographic region) using the
Quarterly National Household Survey (QNHS) [18] and
Census 2006 [19].
Census 2006 population counts were obtained from
the Central Statistics Office and were adjusted for differ-
ences to population between Census 2006 and popula-
tion count estimates 2007.Measurements
All survey respondents were asked if, in the last 12
months, they had been told by a doctor that they had high
blood pressure (yes/no). Respondents in the older sub-
sample (aged 45+ years) were also asked if they were cur-
rently taking medication for high blood pressure (yes/no)
and had their blood pressure objectively measured. Rest-
ing, sitting blood pressure was measured in the right
upper arm using an OMRON 705IT Digital Automatic
Blood Pressure Monitor. Three readings were measured
per respondent and the mean of the second and third
readings were used for analysis. This older sub-sample
(aged 45+ years) was used to estimate the prevalence of
undiagnosed hypertension amongst those aged 45+ years.
Respondents were classified as having undiagnosed
hypertension based on the following criteria: i) they did
not self-report a doctor diagnosis in the past 12 months,
and ii) they had physically measured hypertension
(≥140 mmHg SBP or ≥90 mmHg DBP) and/or were
Table 1 Explanatory variables included in the stepwise






















Cigarette smoking Never smoked
Former smoker
Current smoker
Alcohol consumption Never/monthly or less/2-4
times per month
2-3 times per week
4+ times per week
Fruit and vegetable consumption < 5 portions per day
5+ portions per day
Salt use while cooking Always/usually, sometimes
Sometimes
Rarely/never
Salt use at the table Always/usually, sometimes
Sometimes
Rarely/never






Social class SC 1-2 (Professional and managerial)
SC 3-4
(Non-manual and skilled manual)
SC 5-6 (Semi-skilled and unskilled)
Unclassified
Area deprivation [20] Quintiles
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lence of hypertension (diagnosed and undiagnosed)
amongst adults aged 45+ years was taken to be the sum
of the doctor-diagnosed rate and the undiagnosed rate.
Table 1 shows the socio-demographic and lifestyle var-
iables that were available for all respondents. These were
the potential explanatory variables for a statistical model
of self-reported, doctor-diagnosed hypertension. Actual
height, weight and waist circumference were measured
for the 2,170 respondents in the younger sub-sample
(aged 18-44 years) and the older sub-sample (aged 45+
years). BMI was calculated for the remaining respon-
dents by multiplying self-reported weight and height by
an adjustment factor which ensured that, in each sex-
age category, the mean of the adjusted self-reported
BMIs matched the mean measured BMI in the associ-
ated sub-sample. The adjustment factors were larger for
females and older respondents, ranging from 1.03 to
1.08.
Statistical modelling
All models were developed using weighted data. Self-
reported, doctor-diagnosed hypertension (rather than
physically measured hypertension) was chosen as the
model outcome because it was available for all adult age
groups (18+ years compared with 45+ years) and with a
larger sample (10,201 respondents aged 18+ years com-
pared with 1,201 respondents aged 45+ years).
A stepwise selection logistic regression procedure [21]
was used to develop a statistical model of this outcome
(see Figure 1). The selection procedure (SAS Version 9.2
PROC LOGISTIC, entry p-value = 0.05, exit p-value =
0.05) [22] identified which of the socio-demographic and
lifestyle variables listed in Tale 1 were multvariably asso-
ciated with doctor-diagnosed hypertension. The initial
selection of explanatory variables consisted of age, BMI,
smoking, fruit and vegetable consumption, employment
status, physical activity and salt use at the table.
A national model was developed from the initial selec-
tion of explanatory variables. The national model was
required to satisfy a number of statistical modelling cri-
teria: i) at least ten hypertension cases per explanatory
variable in the model [23], ii) at least 95% of the model’s
cells had five or more observations [24], iii) at least one
modifiable explanatory variable in the model. To satisfy
criterion ii) it was necessary to reduce the number of
cells in the initial selection of explanatory variables so
that a sufficient number of cells had a sufficient number
of observations. The number of cells in the initial selec-
tion of explanatory variables was reduced by removing
weaker explanatory variables (based on the Chi-Square
statistic adjusted for other explanatory variables included
in the model) until criterion ii) was satisfied. The weaker
explanatory variables removed from the initial selection
Figure 1 Method for estimating the national and subnational prevalence of self-reported, doctor-diagnosed hypertension.
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activity and salt use at the table. The remaining explana-
tory variables (age, BMI, smoking, fruit and vegetable con-
sumption) were then refitted as a national model that
satisfied all three statistical modelling criteria. The model
was refit using PROC SURVEYLOGISTIC which takes
into account geographical clustering in the sample design.
The model divided the population into risk groups defined
by the categories of the explanatory variables and provided
an estimate of the risk (at national level) of having doctor-
diagnosed hypertension in each of these risk groups.Subnational prevalence
Developing a subnational model of hypertension risk
Health services in the Republic of Ireland are delivered by
the Health Service Executive through 32 Local Health
Offices (LHOs). Two criteria were used to modify the na-
tional model to obtain a subnational model that could be
used to estimate prevalence for these subnational LHOs.
These criteria were: i) data on the explanatory variables
needed to be available for LHOs so that the number of
people in each of the risk groups in LHOs could be esti-
mated, and ii) the prevalence estimates for LHOs needed
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number of cases had a relative standard error of 30% or
less (that is, the standard error of the estimate was no
more than 30 per cent of the estimate) [25].
Age was the only explanatory variable in the national
model for which data were available for LHOs.
Data on the other explanatory variables (smoking, BMI,
fruit and vegetable consumption) were not available for
LHOs and these explanatory variables were removed from
the model. A subnational model consisting of only age
was refit using the same observations as the national
model so that the national and subnational models would
produce consistent prevalence estimates.
Constructing the subnational risk group populations
LHO population counts by age and sex were obtained
from Census 2006. Population count estimates are not
routinely produced for LHOs but are produced for eight
larger subnational areas (Regional Authorities) [26]. Age-
sex specific changes in population between Census 2006
and 2007 population estimates were calculated for each
Regional Authority. These Regional Authority adjustment
factors were applied to age-sex specific LHO population
counts from Census 2006 to approximate 2007 LHO
population estimates by age.
Calculating the estimated number of cases in the
subnational populations
The subnational model’s age group risk estimates were
multiplied by the corresponding LHO age group popula-
tion count estimates to estimate the number of adults
with doctor-diagnosed hypertension in 2007. The age-
specific estimated number of cases and prevalence rates
from the model were scaled to be consistent with the
age-specific prevalence rates from the SLÁN survey
without modelling.
In calculating 95% confidence intervals for the preva-
lence estimates we assumed that: i) the age group risk
estimates and the age group population count estimates
in each LHO were statistically independent, and ii) the
number of people in each age group in each LHO in the
population was known without error.
Ethics statement
This study did not require any ethical approval as it in-
volved secondary analyses of publicly available demo-
graphic and population data.
Results
Risk of doctor-diagnosed hypertension amongst adults
aged 18+ years
The national model derived from the stepwise regression
procedure explained significant deviance (Likelihood Ratio
Chi-squared test = 1086.70, df = 10, p < 0.001) and showedno evidence of lack of fit (Hosmer and Lemeshow Chi-
Square test = 9.02, df = 8, p = 0.34). The area under the
ROC curve of 0.7729 (95% CI = 0.7594 - 0.7863) suggests
that the national model’s performance at separating cases
and non-case was “fair.” The explanatory variables in the
model were age, BMI, smoking, and fruit and vegetable
consumption. After adjustment for all other explanatory
variables the risk of self-reported, doctor-diagnosed hyper-
tension was significantly related to age (Chi-Square =
424.10, df = 5, p < 0.001), BMI (Chi-Square = 114.74, df = 2,
p < 0.001), smoking (Chi-Square = 13.11, df = 2, p = 0.001)
and fruit and vegetable consumption (Chi-Square = 8.62,
df = 1, p = 0.003).
Table 2 identifies subgroups of respondents who were at
significantly increased independent risk of self-reported,
doctor-diagnosed hypertension. After adjustment for the
other explanatory variables all age groups were more likely
than those aged 18-34 years to have doctor-diagnosed
hypertension, overweight and obese respondents were
more likely than underweight/normal weight respondents
to have doctor-diagnosed hypertension, current smokers
and former smokers were more likely than people who
never smoked to have doctor-diagnosed hypertension, and
respondents who ate less fruit and vegetables were more
likely to have doctor-diagnosed hypertension.
Prevalence of doctor-diagnosed hypertension amongst
adults aged 18+ years
It was estimated that 12.6% (95% CI = 11.7% - 13.4%) of
adults aged 18+ years in the Republic of Ireland had
doctor-diagnosed hypertension in 2007. The prevalence of
doctor-diagnosed hypertension was similar amongst males
and females aged 18-44 years (p = 0.96) and males and fe-
males aged 45+ years (p = 0.25). Doctor-diagnosed hyper-
tension was significantly more common among older
respondents (see Figure 2).
Prevalence of doctor-diagnosed and undiagnosed
hypertension amongst adults aged 45+ years
Table 3 describes the prevalence of doctor-diagnosed and
undiagnosed hypertension amongst adults aged 45+ years.
The prevalence of undiagnosed hypertension was signifi-
cantly higher than diagnosed hypertension for both men
and women aged 45+ years. The prevalence of undiagnosed
hypertension was significantly higher among men aged 45+
years (46.8%, 95% CI 41.2% - 52.4%) than women aged 45+
years (31.2%, 95% CI 25.7% - 36.6%).
Subnational variation in prevalence of doctor-diagnosed
hypertension amongst adults aged 18+ years
The area under the ROC curve of the subnational model
(0.7508, 95% CI = 0.7374 - 0.7643) was not significantly
different to that of the national model (0.7729, 95% CI =
0.7594 - 0.7863). These classification statistics are similar
Table 2 Odds ratios for the national model of self-reported, doctor-diagnosed hypertension
Odds ratio (OR) 95% CI for OR Pr > ChiSq
Age 18-34 years (reference) 1.00
35-44 years 2.02 1.42 - 2.87 <.0001
45-54 years 5.46 3.95 - 7.54 <.0001
55-64 years 10.68 7.75 - 14.73 <.0001
65-74 years 12.92 9.04 - 18.46 <.0001
75+ years 14.45 9.77 - 21.40 <.0001
BMI Underweight/normal (reference) 1.00
Overweight 25-29.99 1.57 1.27 - 1.95 <.0001
Obese 30+ 3.20 2.57 - 3.98 <.0001
Smoking Never smoked (reference) 1.00
Current smoker 1.28 1.04 - 1.58 0.0209
Former smoker 1.40 1.15 - 1.70 0.0007
Fruit and vegetables 5 or more portions (reference) 1.00
Less than 5 portions 1.30 1.09 - 1.56 0.0033
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the strongest predictor of diagnosed hypertension – age.
Figure 3 shows the subnational variation in the
prevalence of doctor-diagnosed hypertension amongst
adults aged 18+ years. Although the national model in-
cluded four explanatory variables (age, BMI, smoking,
and fruit and vegetable consumption), the subnational
model only included age because age was the only ex-
planatory variable for which data were available at
LHO level. Therefore, LHO variation in prevalence
was determined only by differences in the age structure
of the LHO populations.Figure 2 Prevalence of self-reported, doctor-diagnosed hypertensionPairwise comparisons of 95% confidence intervals re-
vealed no statistically significant variation in the preva-
lence of doctor-diagnosed hypertension across the LHOs.
However, because the LHOs have different adult popula-
tion sizes, there was substantial variation in the number of




This paper describes a systematic and rigorous approach
to develop a consistent set of national and subnationaland undiagnosed hypertension (Republic of Ireland, 2007).
Table 3 Prevalence of hypertension by sex and age1
Total (diagnosed & undiagnosed) Doctor-diagnosed Undiagnosed Percentage of
cases undiagnosed(95% CI) (95% CI)2 (95% CI)3
Sex
Males 71.0% (65.1% - 77.0%) 24.2% (22.2% - 26.3%) 46.8% (41.2% - 52.4%) 65.9%
Females 53.7% (48.0% - 59.4%) 22.5% (20.6% - 24.5%) 31.2% (25.7% - 36.6%) 58.0%
Age (persons)
45+ years 62.0% (57.8% - 66.3%) 23.4% (22.0% - 24.7%) 38.7% (34.6% - 42.8%) 62.4%
45-54 years 48.8% (42.5% - 55.0%) 15.0% (12.9% - 17.0%) 33.8% (27.8% - 39.8%) 69.3%
55-64 years 65.1% (57.0% - 73.2%) 26.3% (23.5% - 29.1%) 38.9% (31.2% - 46.5%) 59.7%
65–74 years 71.8% (62.6% - 80.9%) 29.5% (26.2% - 32.9%) 42.2% (33.7% - 50.8%) 58.8%
75+ years 78.7% (63.0% - 94.5%) 30.9% (26.2% - 35.6%) 47.8% (32.7% - 62.9%) 60.8%
Age (males)
45+ years 71.0% (65.1% - 77.0%) 24.2% (22.2% - 26.3%) 46.8% (41.2% - 52.4%) 65.9%
45-54 years 61.1% (51.5% - 70.6%) 16.2% (13.0% - 19.5%) 44.8% (35.8% - 53.8%) 73.4%
55-64 years 70.1% (58.2% - 82.0%) 28.3% (24.0% - 32.5%) 41.8% (30.7% - 53.0%) 59.7%
65–74 years 83.9% (72.4% - 95.5%) 31.5% (27.1% - 36.0%) 52.4% (41.7% - 63.1%) 62.4%
75+ years 86.5% (68.0% - 105.1%) 27.8% (22.1% - 33.4%) 58.8% (41.0% - 76.6%) 67.9%
Age (females)
45+ years 53.7% (48.0% - 59.4%) 22.5% (20.6% - 24.5%) 31.2% (25.7% - 36.6%) 58.0%
45-54 years 36.5% (28.6% - 44.3%) 13.7% (11.1% - 16.3%) 22.7% (15.3% - 30.2%) 62.4%
55-64 years 60.3% (49.9% - 70.6%) 24.3% (20.6% - 28.1%) 35.9% (26.3% - 45.6%) 59.6%
65–74 years 60.8% (47.6% - 74.0%) 27.7% (22.6% - 32.9%) 33.1% (20.9% - 45.3%) 54.4%
75+ years 73.6% (52.3% - 95.0%) 32.9% (26.5% - 39.4%) 40.7% (20.3% - 61.1%) 55.3%
1Some column totals will differ from sum of corresponding entries because of rounding error.
2Based on the full sample.
3Based on the older physical measurement sub-sample only.
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lic of Ireland, a country with inadequate national and sub-
national outcome and risk factor data. The method
described here (see Figure 1) builds on methods developed
by the APHO [10] and has a number of advantages. It is
systematic and can be implemented for any condition for
which we have a good quality reference study to model
the risk of the condition. It is also flexible and could in-
corporate better input data (reference study and/or popu-
lation data) if and when they are available.
The prevalence of self-reported, doctor-diagnosed hyper-
tension in the previous 12 months found here (12.6%
among adults aged 18+ years) was similar to other surveys
from the Republic of Ireland. The QNHS’s prevalence of
self-reported, doctor-diagnosed hypertension at any time
in the past among adults aged 18+ years was 10% in 2007
[8] and 11% in 2010 [27]. In Northern Ireland among
adults aged 16+ years, Understanding Society 2009 [28] re-
ported similar prevalence (15% at any time in the past) but
the Health and Social Wellbeing Survey 2005/2006 [29] re-
ported a higher prevalence (25% at any time in the past).
The explanatory model of doctor-diagnosed hypertension
showed that older adults, overweight and obese adults,current and former smokers, and adults who eat less fruit
and vegetables were more likely to have doctor-diagnosed
hypertension. There was no statistically significant vari-
ation in the prevalence of doctor-diagnosed hypertension
amongst adults across the subnational areas.
In our study, the total prevalence of hypertension (di-
agnosed and undiagnosed; 62% among adults aged 45+
years) included people who had physically measured
hypertension or who reported a doctor diagnosis of hyper-
tension in the previous 12 months. This more inclusive
definition contributed to a higher estimated prevalence
than estimates from other national and international sur-
veys based on physical measurement alone. The Irish
Longitudinal Study on Ageing (TILDA) estimated that
43% of adults aged 50+ years have physically measured
hypertension [30] but this estimate excluded people with
hypertension controlled by medication. The Health Survey
for England 2011 estimated that 47% of adults aged 45+
years hade physically measured hypertension [31]. In the
US the National Health and Nutrition Examination Survey
(NHANES) 2009/2010 estimated that 30% of 40-59 years
olds and 67% of 60+ year olds had physically measured
hypertension [32].
Figure 3 Prevalence of self-reported, doctor-diagnosed hypertension among adults by Local Health Offices (Republic of Ireland, 2007).
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(62%) were undiagnosed and men were more likely than
women to have undiagnosed hypertension. TILDA also
found that a slight majority of cases were undiagnosed in
the Republic of Ireland (53% of cases among 50+ year
olds). The HSfE 2011 found that a third of cases among
35+ year olds in England were undiagnosed while
NHANES 2009/2010 found that only one sixth of cases
among 40+ year olds in the US were undiagnosed.Limitations
There were a number of limitations to SLÁN 2007 for
modelling the risk of hypertension and to the population
data on hypertension risk factors.
The hypertension outcome used in the explanatory
model of SLÁN 2007 data was self-reported, doctor-
diagnosed hypertension in the previous 12 months because
it was available for the full sample of adults aged 18+ years.
Physically measured blood pressure was only available for a
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findings from the older sub-sample, where the significant
majority of hypertension was undiagnosed, showed that
self-reported, doctor-diagnosed hypertension was a sub-
stantial underestimate of the population prevalence of
hypertension.
Inadequate sample size contributed to an insufficient
number of observations in the risk groups of the initial se-
lection of explanatory variables and this may bias the risk
estimates produced from such a model. A model with fewer
explanatory variables (and therefore fewer risk groups and
more observations in each risk group) may reduce bias in
the risk estimates. Three weaker significant explanatory var-
iables were removed from the initial selection to achieve
adequate sample sizes in the risk groups for the national
model. Although this may reduce bias in the risk estimates,
it also reduced the model’s goodness of fit.
Inadequate sample size and a sampling design that
was not representative at subnational areas prohibited
the development of different models for different subna-
tional areas.
The response rate for the main survey was 62%. The re-
sponse rate within these respondents to the main survey
was 58% for the younger sub-sample and 60% for the older
sub-sample.
In addition to the limitations to the survey data for
modelling the risk of hypertension, there were substan-
tial limitations to the data available to describe the dis-
tribution of risk in subnational populations. Population
count estimates by age are routinely produced for eight
Regional Authority areas but not for smaller LHO areas.
Data on behavioural and social risk factors for hyperten-
sion were not available for LHOs and these factors were
removed when specifying the subnational model. These
limitations prevented us from properly describing the
distribution of risk in LHOs and were likely to mask
LHO variation in the prevalence of hypertension.
Conclusions and recommendations
The findings suggest that a large number of adults in the
Republic of Ireland are living with hypertension and that
the majority of cases are undiagnosed. They highlight the
need for services to manage diagnosed hypertension cases
and to detect and manage undiagnosed cases. Symptoms
of hypertension are often hidden and people often do not
know that they have hypertension until their blood pres-
sure is measured. Regular blood pressure measurement in
primary care allows early detection and treatment of
hypertension that can avoid further damage to health. The
Republic of Ireland’s national cardiovascular health policy
[33] recommends that the effective management of hyper-
tension should be prioritised in primary care and calls for
guidelines on standards of assessment, management and
review of patients based on best practice.It is important to emphasise that hypertension can be
prevented and that population measures such as mandatory
and voluntary reductions of salt content in processed foods
are more cost effective than treatment [34]. Individuals
should be educated about the dangers of hypertension and
encouraged to reduce their risk of hypertension by hav-
ing a healthy lifestyle: eating a balanced diet, maintain-
ing a healthy weight, reducing salt intake, not smoking,
and avoiding harmful use of alcohol. The World Health
Organization (WHO) [35], the Republic of Ireland’s na-
tional cardiovascular health policy [33], and the Repub-
lic of Ireland’s framework for improved health and
wellbeing [36] identify population level improvements
in these risk factors for hypertension as key in an inte-
grated approach to preventing cardiovascular disease.
The WHO also highlights the importance of collect-
ing reliable data on cardiovascular risk factors and their
determinants for policy and programme development
[2]. This study found that there are substantial limita-
tions to the data available on hypertension and its risk
factors. The following recommendations would improve
the data available for monitoring the prevalence of
hypertension and its risk factors: i) national health sur-
veys should include physical measurements of blood
pressure in all participants in addition to self-reported
recall of a hypertension diagnosis, ii) larger sample sizes
in these studies would allow more robust and precise
risk estimates and could also allow the development of
different prevalence models for different subnational
areas, iii) higher response rates may reduce potential
sampling bias and produce more accurate results, and
iv) better subnational data on behavioural and social
risk factors for hypertension would allow a better de-
scription of the distribution of hypertension risk and
hypertension prevalence in subnational areas.
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